Used in in vitro transcription to produce high yields of RNA with enhanced stability and reduced immunogenicity. The incorporation of N1-Me-pUTP improves RNA capping efficiency and supports robust expression of functional RNA for applications in mRNA vaccines, therapeutic protein expression, and RNA-based research. Its modified nucleotide structure increases translational efficiency and helps evade innate immune detection, making it ideal for sensitive cellular assays and clinical-grade RNA production.